Shah Capital, Novavax's second-largest shareholder, is pressing the biotech's board to pursue strategic changes, including a ...

The 2025-2026 respiratory viral season is approaching.With it comes the familiar challenge of protecting our most vulnerable ...

Q3 2025 Earnings Call Transcript November 6, 2025 Novavax, Inc. misses on earnings expectations. Reported EPS is $-1.24654 ...

India's Coronavirus Vaccine Market offers growth through government-led initiatives, robust manufacturing, and R&D in vaccine ...

Novavax Inc (NVAX) focuses on innovation and partnerships amid financial hurdles, aiming for profitability by 2028.

Novavax (($NVAX)) has held its Q3 earnings call. Read on for the main highlights of the call. Novavax’s Q3 2025 Earnings Call: A Cautiously ...

Pfizer (PFE) stock is in focus as the company exceeds Street forecasts with its Q3 2025 results thanks mainly to its COVID ...

President Donald Trump has received updated flu and COVID-19 booster shots in preparation for upcoming travel, the president’s physician announced Oct. 10. Sean P. Barbabella, a U.S. Navy captain, ...

Front Range Pharmacy has announced expanded vaccination accessibility at its Englewood location following a statewide regulatory update that now allows pharmacists to administer vaccines without ...